Aromatic Amino Acid Decarboxylation Inhibitor [EPC]

Aromatic Amino Acid Decarboxylation Inhibitor [EPC] was reported 28256 times

These side effects are most commonly reported by patients taking drugs of the Aromatic Amino Acid Decarboxylation Inhibitor [EPC] class:

# Drug class Count
0 HALLUCINATION 2711
1 FALL 2690
2 DRUG INEFFECTIVE 2586
3 DEATH 1830
4 DYSKINESIA 1704
5 PARKINSON^S DISEASE 1648
6 CONFUSIONAL STATE 1593
7 TREMOR 1580
8 DIZZINESS 1484
9 NAUSEA 1443
10 FATIGUE 1410
11 GAIT DISTURBANCE 1385
12 SOMNOLENCE 1341
13 ASTHENIA 1143
14 CONDITION AGGRAVATED 985
15 CONSTIPATION 958
16 ANXIETY 934
17 URINARY TRACT INFECTION 934
18 INSOMNIA 880
19 DYSPNOEA 877
20 MALAISE 860
21 WEIGHT DECREASED 825
22 ON AND OFF PHENOMENON 800
23 FEELING ABNORMAL 758
24 PAIN 742
25 HALLUCINATION, VISUAL 720
26 HYPOTENSION 713
27 VOMITING 713
28 BALANCE DISORDER 704
29 COUGH 698
30 PNEUMONIA 673
31 DIARRHOEA 668
32 DYSPHAGIA 638
33 OFF LABEL USE 637
34 DEPRESSION 633
35 DRUG INTERACTION 633
36 PRODUCT DOSE OMISSION ISSUE 607
37 HEADACHE 592
38 DEVICE ISSUE 582
39 MEMORY IMPAIRMENT 574
40 MOBILITY DECREASED 573
41 AGITATION 565
42 FREEZING PHENOMENON 553
43 MUSCULOSKELETAL STIFFNESS 553
44 DELUSION 551
45 SPEECH DISORDER 541
46 MUSCLE RIGIDITY 535
47 DECREASED APPETITE 532
48 LOSS OF CONSCIOUSNESS 516
49 PAIN IN EXTREMITY 495
50 DEMENTIA 451
51 MUSCLE SPASMS 444
52 ABNORMAL BEHAVIOUR 439
53 GENERAL PHYSICAL HEALTH DETERIORATION 434
54 AGGRESSION 429
55 PERIPHERAL SWELLING 421
56 SYNCOPE 418
57 HYPERHIDROSIS 417
58 COGNITIVE DISORDER 408
59 DEHYDRATION 393
60 HYPERTENSION 389
61 BRADYKINESIA 387
62 ARTHRALGIA 385
63 MUSCULAR WEAKNESS 385
64 ABDOMINAL PAIN 381
65 DEVICE DISLOCATION 381
66 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 374
67 BACK PAIN 367
68 PYREXIA 359
69 BLOOD PRESSURE INCREASED 354
70 DYSTONIA 344
71 OEDEMA PERIPHERAL 343
72 RASH 329
73 CEREBROVASCULAR ACCIDENT 325
74 SLEEP DISORDER 325
75 PARKINSON'S DISEASE 318
76 BLOOD PRESSURE DECREASED 316
77 UNEVALUABLE EVENT 315
78 OVERDOSE 301
79 DISORIENTATION 298
80 MOVEMENT DISORDER 296
81 INCORRECT DOSE ADMINISTERED 294
82 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 294
83 HIP FRACTURE 293
84 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 292
85 ABNORMAL DREAMS 291
86 GAIT INABILITY 291
87 DRY MOUTH 287
88 DELIRIUM 286
89 STOMA SITE DISCHARGE 285
90 PSYCHOTIC DISORDER 284
91 ORTHOSTATIC HYPOTENSION 282
92 RESTLESSNESS 280
93 DEVICE OCCLUSION 275
94 CHEST PAIN 266
95 HOSPITALISATION 263
96 ABDOMINAL DISCOMFORT 260
97 DYSSTASIA 260
98 ADVERSE DRUG REACTION 253
99 PRURITUS 253
100 THERAPEUTIC RESPONSE SHORTENED 251
101 WEIGHT INCREASED 250
102 STOMA SITE ERYTHEMA 247
103 PRODUCT USE ISSUE 244
104 PNEUMONIA ASPIRATION 242
105 SEPSIS 242
106 ANAEMIA 241
107 NIGHTMARE 240
108 DEPRESSED MOOD 238
109 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 237
110 ABDOMINAL PAIN UPPER 233
111 UNDERDOSE 229
112 PRODUCT USE IN UNAPPROVED INDICATION 227
113 ATRIAL FIBRILLATION 226
114 COVID-19 226
115 HYPOAESTHESIA 226
116 SEIZURE 226
117 CONTUSION 224
118 ADVERSE EVENT 221
119 PARANOIA 221
120 PATHOLOGICAL GAMBLING 221
121 RENAL FAILURE 221
122 VISION BLURRED 217
123 DYSARTHRIA 216
124 PRESCRIBED UNDERDOSE 216
125 DEVICE DIFFICULT TO USE 210
126 LETHARGY 210
127 UNRESPONSIVE TO STIMULI 210
128 HEAD INJURY 209
129 HYPERSOMNIA 208
130 HYPOPHAGIA 208
131 MYOCARDIAL INFARCTION 208
132 SUICIDAL IDEATION 208
133 PARKINSONISM 206
134 PARAESTHESIA 204
135 ABDOMINAL DISTENSION 202
136 DRUG DOSE OMISSION 202
137 PRODUCT DOSE OMISSION 197
138 STRESS 197
139 MYALGIA 192
140 OBSESSIVE-COMPULSIVE DISORDER 192
141 INFECTION 190
142 DISTURBANCE IN ATTENTION 188
143 THERAPEUTIC PRODUCT EFFECT DECREASED 187
144 VISUAL IMPAIRMENT 184
145 NERVOUSNESS 181
146 DISEASE PROGRESSION 180
147 APHASIA 179
148 DRUG EFFECT DECREASED 179
149 ACUTE KIDNEY INJURY 178
150 DRUG HYPERSENSITIVITY 178
151 NOCTURIA 177
152 DYSPHONIA 176
153 ERYTHEMA 175
154 HAEMOGLOBIN DECREASED 174
155 RESTLESS LEGS SYNDROME 170
156 URINARY INCONTINENCE 168
157 DEPRESSED LEVEL OF CONSCIOUSNESS 162
158 PALPITATIONS 162
159 PRODUCT RESIDUE PRESENT 162
160 DRUG INTOLERANCE 160
161 POOR QUALITY SLEEP 160
162 CARDIAC FAILURE CONGESTIVE 159
163 HYPOKINESIA 159
164 EMOTIONAL DISTRESS 156
165 CHOKING 153
166 NONSPECIFIC REACTION 152
167 STOMA SITE PAIN 152
168 THERAPEUTIC RESPONSE UNEXPECTED 152
169 THERAPEUTIC PRODUCT EFFECT VARIABLE 151
170 PULMONARY EMBOLISM 149
171 HYPERSENSITIVITY 147
172 NEUROLEPTIC MALIGNANT SYNDROME 147
173 AMNESIA 146
174 DYSPEPSIA 146
175 BLOOD PRESSURE FLUCTUATION 145
176 NEUROPATHY PERIPHERAL 144
177 RESPIRATORY FAILURE 143
178 GASTROINTESTINAL HAEMORRHAGE 142
179 NASOPHARYNGITIS 140
180 JOINT SWELLING 139
181 PANIC ATTACK 138
182 URINARY RETENTION 138
183 CHEST DISCOMFORT 136
184 MIDDLE INSOMNIA 136
185 GASTROINTESTINAL DISORDER 135
186 POLLAKIURIA 135
187 TREATMENT NONCOMPLIANCE 135
188 ILL-DEFINED DISORDER 133
189 CARDIAC DISORDER 131
190 MENTAL DISORDER 130
191 HYPONATRAEMIA 129
192 INTENTIONAL PRODUCT MISUSE 124
193 MENTAL STATUS CHANGES 123
194 HEART RATE INCREASED 122
195 HYPERSEXUALITY 122
196 CARDIAC ARREST 121
197 IRRITABILITY 121
198 LIMB DISCOMFORT 120
199 TRANSIENT ISCHAEMIC ATTACK 120
200 FEELING HOT 119
201 PSYCHOMOTOR HYPERACTIVITY 117
202 INJURY 116
203 DEVICE BREAKAGE 115
204 DROOLING 115
205 THERAPEUTIC RESPONSE DECREASED 115
206 PRODUCT AVAILABILITY ISSUE 114
207 CARDIAC FAILURE 113
208 DEVICE USE ISSUE 113
209 MEDICATION ERROR 113
210 STOMA SITE INFECTION 113
211 TENSION 113
212 WHITE BLOOD CELL COUNT INCREASED 113
213 FLUSHING 112
214 ILLNESS 112
215 BRONCHITIS 111
216 DEVICE LEAKAGE 111
217 FEAR 111
218 HOT FLUSH 111
219 VERTIGO 111
220 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 111
221 CHILLS 110
222 GASTROOESOPHAGEAL REFLUX DISEASE 110
223 PLEURAL EFFUSION 110
224 TOXICITY TO VARIOUS AGENTS 110
225 BLOOD GLUCOSE INCREASED 109
226 DIPLOPIA 109
227 EATING DISORDER 108
228 NECK PAIN 108
229 ABASIA 107
230 BRADYCARDIA 106
231 INFLUENZA 106
232 RIB FRACTURE 106
233 ANGER 105
234 HALLUCINATION, AUDITORY 105
235 HYPERKINESIA 105
236 PRODUCT SUBSTITUTION ISSUE 105
237 RHABDOMYOLYSIS 105
238 SUICIDE ATTEMPT 104
239 YAWNING 104
240 ALOPECIA 103
241 PHARMACEUTICAL PRODUCT COMPLAINT 103
242 CATARACT 102
243 NO ADVERSE EVENT 102
244 CONVULSION 101
245 POSTURE ABNORMAL 101
246 REDUCED FACIAL EXPRESSION 101
247 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 100
248 PRODUCT QUALITY ISSUE 100
249 SALIVARY HYPERSECRETION 100
250 FEEDING DISORDER 99
251 MOTOR DYSFUNCTION 98
252 REHABILITATION THERAPY 98
253 SWELLING 98
254 TACHYCARDIA 98
255 RHINORRHOEA 97
256 MENTAL IMPAIRMENT 96
257 ARTHRITIS 95
258 THROAT IRRITATION 95
259 MOOD ALTERED 94
260 OSTEOARTHRITIS 94
261 CELLULITIS 93
262 DISCOMFORT 93
263 DYSGEUSIA 93
264 MUSCLE TWITCHING 92
265 BLOOD CREATININE INCREASED 91
266 HOSPICE CARE 90
267 THROMBOCYTOPENIA 90
268 BURNING SENSATION 89
269 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 89
270 SOPOR 89
271 CEREBRAL HAEMORRHAGE 88
272 DEEP BRAIN STIMULATION 88
273 INCONTINENCE 88
274 THERAPY INTERRUPTED 88
275 DEVICE KINK 87
276 CRYING 86
277 HALLUCINATIONS, MIXED 86
278 DEEP VEIN THROMBOSIS 85
279 INITIAL INSOMNIA 85
280 INTESTINAL OBSTRUCTION 85
281 PRESCRIBED OVERDOSE 85
282 SEROTONIN SYNDROME 85
283 CYSTITIS 84
284 IMPULSE-CONTROL DISORDER 84
285 ENCEPHALOPATHY 83
286 INTERNATIONAL NORMALISED RATIO INCREASED 83
287 PRODUCTIVE COUGH 83
288 TARDIVE DYSKINESIA 83
289 ASPIRATION 82
290 BLOOD CREATINE PHOSPHOKINASE INCREASED 82
291 THROMBOSIS 82
292 HAEMORRHAGE 81
293 HEAD DISCOMFORT 81
294 HYPOGLYCAEMIA 81
295 INJECTION SITE PAIN 81
296 OROPHARYNGEAL PAIN 81
297 SEDATION 81
298 URTICARIA 81
299 COMA 80
300 WRONG TECHNIQUE IN DRUG USAGE PROCESS 80
301 FLATULENCE 79
302 EMOTIONAL DISORDER 78
303 EXTRAPYRAMIDAL DISORDER 78
304 PRESYNCOPE 78
305 PRODUCT PHYSICAL ISSUE 78
306 BLOOD CHOLESTEROL INCREASED 77
307 CHRONIC KIDNEY DISEASE 77
308 COMPULSIVE SHOPPING 77
309 FAECALOMA 77
310 OXYGEN SATURATION DECREASED 77
311 THERAPY CESSATION 77
312 DRUG ABUSE 76
313 EPISTAXIS 76
314 HEART RATE DECREASED 76
315 INJECTION SITE ERYTHEMA 76
316 NEPHROLITHIASIS 76
317 RENAL FAILURE ACUTE 76
318 ROAD TRAFFIC ACCIDENT 76
319 STOMA SITE HYPERGRANULATION 76
320 MICTURITION URGENCY 75
321 DOPAMINE DYSREGULATION SYNDROME 74
322 HYPOXIA 74
323 PULMONARY OEDEMA 74
324 THERAPY NON-RESPONDER 74
325 WITHDRAWAL SYNDROME 74
326 FEMUR FRACTURE 73
327 FLUID RETENTION 73
328 INTENTIONAL PRODUCT USE ISSUE 73
329 MANIA 73
330 SKIN DISCOLOURATION 73
331 ACTIVITIES OF DAILY LIVING IMPAIRED 72
332 MUSCULOSKELETAL PAIN 72
333 CHROMATURIA 71
334 DIABETES MELLITUS 71
335 ECONOMIC PROBLEM 71
336 STOMA SITE HAEMORRHAGE 71
337 ALTERED STATE OF CONSCIOUSNESS 70
338 DRUG EFFECT INCOMPLETE 70
339 DYSURIA 70
340 INTENTIONAL UNDERDOSE 70
341 LIMB INJURY 70
342 LUNG DISORDER 70
343 MITRAL VALVE INCOMPETENCE 70
344 SKIN LACERATION 70
345 AKINESIA 69
346 BLISTER 69
347 DECUBITUS ULCER 69
348 OEDEMA 69
349 RECTAL HAEMORRHAGE 69
350 ARRHYTHMIA 68
351 SURGERY 68
352 THINKING ABNORMAL 68
353 UPPER LIMB FRACTURE 68
354 ACUTE MYOCARDIAL INFARCTION 67
355 ASTHMA 67
356 NEUTROPENIA 67
357 WHITE BLOOD CELL COUNT DECREASED 67
358 BEDRIDDEN 66
359 DRUG WITHDRAWAL SYNDROME 66
360 LOWER RESPIRATORY TRACT INFECTION 66
361 PLATELET COUNT DECREASED 66
362 HAEMATURIA 65
363 SINUSITIS 65
364 STOMA SITE IRRITATION 65
365 STOMA SITE REACTION 65
366 DRUG EFFECT LESS THAN EXPECTED 64
367 ILEUS 64
368 INTENTIONAL OVERDOSE 64
369 MUSCLE TIGHTNESS 64
370 PALLOR 64
371 PARALYSIS 64
372 AORTIC VALVE INCOMPETENCE 63
373 APATHY 63
374 ARTHROPATHY 63
375 ASPARTATE AMINOTRANSFERASE INCREASED 63
376 BLOOD POTASSIUM DECREASED 63
377 FLUID INTAKE REDUCED 63
378 PANCREATITIS 63
379 ABNORMAL FAECES 62
380 DEVICE ALARM ISSUE 62
381 DIZZINESS POSTURAL 62
382 LIBIDO INCREASED 62
383 MOOD SWINGS 62
384 MUSCULOSKELETAL DISORDER 62
385 TRICUSPID VALVE INCOMPETENCE 62
386 DEMENTIA WITH LEWY BODIES 61
387 NASAL CONGESTION 61
388 RESPIRATORY DISORDER 61
389 SENSORY DISTURBANCE 61
390 BRADYPHRENIA 60
391 PRODUCT ADMINISTRATION ERROR 60
392 BEHAVIOUR DISORDER 59
393 BOWEL MOVEMENT IRREGULARITY 59
394 CHOLELITHIASIS 59
395 CORONARY ARTERY DISEASE 59
396 EMBEDDED DEVICE 59
397 HAEMATOCRIT DECREASED 59
398 TERMINAL STATE 59
399 THERAPEUTIC PRODUCT EFFECT DELAYED 59
400 BLADDER DISORDER 58
401 FEELING COLD 58
402 FEELING JITTERY 58
403 HYPOKALAEMIA 58
404 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 58
405 PERSONALITY CHANGE 58
406 SLEEP APNOEA SYNDROME 58
407 SUBDURAL HAEMATOMA 58
408 SWELLING FACE 58
409 BLOOD UREA INCREASED 57
410 COLITIS 57
411 DRY EYE 57
412 GASTRIC DISORDER 57
413 IMPULSIVE BEHAVIOUR 57
414 INCORRECT DOSE ADMINISTERED BY DEVICE 57
415 OSTEOPOROSIS 57
416 RENAL IMPAIRMENT 57
417 RETCHING 57
418 FIBROMA 56
419 MIGRAINE 56
420 BLOOD PRESSURE ABNORMAL 55
421 HYPOACUSIS 55
422 BLOOD ALKALINE PHOSPHATASE INCREASED 54
423 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 54
424 EXTRA DOSE ADMINISTERED 54
425 HERPES ZOSTER 54
426 MALNUTRITION 54
427 SCREAMING 54
428 STAPHYLOCOCCAL INFECTION 54
429 TINNITUS 54
430 COORDINATION ABNORMAL 53
431 DEVICE CONNECTION ISSUE 53
432 DRY SKIN 53
433 ELECTROCARDIOGRAM QT PROLONGED 53
434 INFLUENZA LIKE ILLNESS 53
435 NEURALGIA 53
436 RASH PRURITIC 53
437 SPUTUM DISCOLOURED 53
438 WRIST FRACTURE 53
439 NEOPLASM MALIGNANT 52
440 RESPIRATORY DISTRESS 52
441 ALANINE AMINOTRANSFERASE INCREASED 51
442 ANOSMIA 51
443 BONE PAIN 51
444 CARDIO-RESPIRATORY ARREST 51
445 DYSPNOEA EXERTIONAL 51
446 PRODUCT USE COMPLAINT 51
447 AGEUSIA 50
448 HAEMATOMA 50
449 RED BLOOD CELL COUNT DECREASED 50
450 SLUGGISHNESS 50
451 ANAL INCONTINENCE 49
452 APPLICATION SITE PRURITUS 49
453 BLOOD GLUCOSE DECREASED 49
454 DECREASED INTEREST 49
455 HEART RATE IRREGULAR 49
456 HYPERKALAEMIA 49
457 LACRIMATION INCREASED 49
458 PRODUCT PRESCRIBING ERROR 49
459 PSORIASIS 49
460 ACUTE RESPIRATORY FAILURE 48
461 APPLICATION SITE ERYTHEMA 48
462 INCOHERENT 48
463 JOINT INJURY 48
464 POST PROCEDURAL COMPLICATION 48
465 STOMA SITE INFLAMMATION 48
466 SUDDEN ONSET OF SLEEP 48
467 BLOOD SODIUM DECREASED 47
468 CATATONIA 47
469 COMMUNICATION DISORDER 47
470 DYSGRAPHIA 47
471 GAMBLING 47
472 HAEMATOCHEZIA 47
473 HYPERPHAGIA 47
474 IMMOBILE 47
475 SKIN ULCER 47
476 SPINAL OSTEOARTHRITIS 47
477 WHEEZING 47
478 CEREBRAL ATROPHY 46
479 FINE MOTOR SKILL DYSFUNCTION 46
480 LIVING IN RESIDENTIAL INSTITUTION 46
481 NERVOUS SYSTEM DISORDER 46
482 RASH ERYTHEMATOUS 46
483 SKIN EXFOLIATION 46
484 UROSEPSIS 46
485 DRUG DEPENDENCE 45
486 FAECES DISCOLOURED 45
487 HYPERLIPIDAEMIA 45
488 INFUSION SITE ERYTHEMA 45
489 INFUSION SITE PAIN 45
490 INJECTION SITE BRUISING 45
491 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 45
492 JOINT STIFFNESS 45
493 PELVIC FRACTURE 45
494 PRODUCT DISPENSING ERROR 45
495 UPPER RESPIRATORY TRACT INFECTION 45
496 WHEELCHAIR USER 45
497 ACCIDENTAL OVERDOSE 44
498 COMPLICATION ASSOCIATED WITH DEVICE 44
499 GASTRITIS 44
500 INTERVERTEBRAL DISC PROTRUSION 44
501 LOWER LIMB FRACTURE 44
502 PULMONARY HYPERTENSION 44
503 RESPIRATORY TRACT INFECTION 44
504 SPINAL FRACTURE 44
505 WALKING AID USER 44
506 COMPLETED SUICIDE 43
507 DRUG ADMINISTRATION ERROR 43
508 GLAUCOMA 43
509 PRODUCT DOSE OMISSION IN ERROR 43
510 SWOLLEN TONGUE 43
511 CARDIOMEGALY 42
512 COLD SWEAT 42
513 DYSCHEZIA 42
514 FOOT DEFORMITY 42
515 LIP SWELLING 42
516 MELAENA 42
517 SUDDEN DEATH 42
518 WOUND 42
519 BLINDNESS 41
520 C-REACTIVE PROTEIN INCREASED 41
521 CLOSTRIDIUM DIFFICILE INFECTION 41
522 DECREASED ACTIVITY 41
523 EYE DISORDER 41
524 INJECTION SITE PRURITUS 41
525 APPLICATION SITE REACTION 40
526 BENIGN PROSTATIC HYPERPLASIA 40
527 DEVICE PHYSICAL PROPERTY ISSUE 40
528 EPILEPSY 40
529 EXPIRED PRODUCT ADMINISTERED 40
530 FAILURE TO THRIVE 40
531 HAEMATEMESIS 40
532 HIATUS HERNIA 40
533 INFLAMMATION 40
534 PARKINSONIAN GAIT 40
535 PRODUCT PRESCRIBING ISSUE 40
536 RENAL DISORDER 40
537 EYE PAIN 39
538 LACTIC ACIDOSIS 39
539 LEUKOPENIA 39
540 LOCALISED INFECTION 39
541 MYOCLONUS 39
542 OSTEOMYELITIS 39
543 PAIN IN JAW 39
544 RESPIRATORY ARREST 39
545 SEPTIC SHOCK 39
546 SPINAL OPERATION 39
547 STOMATITIS 39
548 THROAT TIGHTNESS 39
549 AKATHISIA 38
550 GAMBLING DISORDER 38
551 GENERAL SYMPTOM 38
552 HYPERGLYCAEMIA 38
553 INTENTIONAL DOSE OMISSION 38
554 NIGHT SWEATS 38
555 PERIPHERAL COLDNESS 38
556 PERSECUTORY DELUSION 38
557 QUALITY OF LIFE DECREASED 38
558 UNINTENTIONAL MEDICAL DEVICE REMOVAL 38
559 BLOOD PRESSURE SYSTOLIC INCREASED 37
560 HYPOTHYROIDISM 37
561 ORAL DISCOMFORT 37
562 PRODUCT STORAGE ERROR 37
563 ABDOMINAL TENDERNESS 36
564 ATAXIA 36
565 CARPAL TUNNEL SYNDROME 36
566 FREQUENT BOWEL MOVEMENTS 36
567 HEPATIC ENZYME INCREASED 36
568 HERNIA 36
569 JAUNDICE 36
570 MALIGNANT MELANOMA 36
571 ORAL PAIN 36
572 PROSTATE CANCER 36
573 SOMNAMBULISM 36
574 SUBARACHNOID HAEMORRHAGE 36
575 TRISMUS 36
576 ANURIA 35
577 BLOOD URINE PRESENT 35
578 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 35
579 ERECTILE DYSFUNCTION 35
580 FRACTURE 35
581 GASTROINTESTINAL SOUNDS ABNORMAL 35
582 HEMIPARESIS 35
583 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 35
584 KNEE ARTHROPLASTY 35
585 SKIN IRRITATION 35
586 SLEEP TALKING 35
587 SPINAL COMPRESSION FRACTURE 35
588 SUBILEUS 35
589 ANKLE FRACTURE 34
590 ANOREXIA 34
591 BRAIN FOG 34
592 CEREBRAL INFARCTION 34
593 DEVICE MALFUNCTION 34
594 DEVICE USE ERROR 34
595 DRUG EFFECT DELAYED 34
596 FAECES HARD 34
597 FRUSTRATION TOLERANCE DECREASED 34
598 HAEMORRHOIDS 34
599 HIP ARTHROPLASTY 34
600 HYPERVENTILATION 34
601 HYPOMAGNESAEMIA 34
602 INCREASED APPETITE 34
603 LACERATION 34
604 OCULAR HYPERAEMIA 34
605 PARKINSON^S DISEASE PSYCHOSIS 34
606 PROCEDURAL PAIN 34
607 ABDOMINAL PAIN LOWER 33
608 ANGINA PECTORIS 33
609 IMPAIRED HEALING 33
610 MUSCLE ATROPHY 33
611 PANIC REACTION 33
612 SEXUAL DYSFUNCTION 33
613 STOMA SITE EXTRAVASATION 33
614 ANTICHOLINERGIC SYNDROME 32
615 AUTONOMIC NERVOUS SYSTEM IMBALANCE 32
616 BLOOD IRON DECREASED 32
617 CHOREA 32
618 DEVICE DELIVERY SYSTEM ISSUE 32
619 DIVERTICULITIS 32
620 EOSINOPHILIA 32
621 FACE INJURY 32
622 GASTRIC ULCER 32
623 HYPERTENSIVE CRISIS 32
624 INJECTION SITE SWELLING 32
625 LEUKOCYTOSIS 32
626 MUSCULOSKELETAL CHEST PAIN 32
627 PRODUCT ADHESION ISSUE 32
628 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 32
629 SKIN DISORDER 32
630 VIRAL INFECTION 32
631 BLOOD POTASSIUM INCREASED 31
632 BRUXISM 31
633 CYANOSIS 31
634 DEAFNESS 31
635 ECZEMA 31
636 EUPHORIC MOOD 31
637 EYE IRRITATION 31
638 HAND FRACTURE 31
639 IMPAIRED DRIVING ABILITY 31
640 IMPAIRED GASTRIC EMPTYING 31
641 INJECTION SITE MASS 31
642 JEALOUS DELUSION 31
643 MALIGNANT NEOPLASM PROGRESSION 31
644 MUSCLE STRAIN 31
645 MYOCARDIAL ISCHAEMIA 31
646 TROPONIN INCREASED 31
647 TYPE 2 DIABETES MELLITUS 31
648 ATELECTASIS 30
649 CATHETER SITE ERYTHEMA 30
650 CONTRAINDICATED PRODUCT ADMINISTERED 30
651 FEMORAL NECK FRACTURE 30
652 JOINT RANGE OF MOTION DECREASED 30
653 MEDICAL DEVICE DISCOMFORT 30
654 PARKINSONISM HYPERPYREXIA SYNDROME 30
655 POLYNEUROPATHY 30
656 SCIATICA 30
657 SLEEP TERROR 30
658 TREATMENT FAILURE 30
659 BACK DISORDER 29
660 CLAVICLE FRACTURE 29
661 DENTAL CARIES 29
662 DEVICE LOOSENING 29
663 FOOT FRACTURE 29
664 GAMMA-GLUTAMYLTRANSFERASE INCREASED 29
665 HYPERTHERMIA 29
666 ILLUSION 29
667 IMPAIRED QUALITY OF LIFE 29
668 INJECTION SITE HAEMORRHAGE 29
669 PROSTATIC SPECIFIC ANTIGEN INCREASED 29
670 STARING 29
671 STOMA SITE ODOUR 29
672 BODY HEIGHT DECREASED 28
673 BODY TEMPERATURE INCREASED 28
674 CATHETER SITE PAIN 28
675 EYELID PTOSIS 28
676 GASTROENTERITIS VIRAL 28
677 GASTROINTESTINAL MOTILITY DISORDER 28
678 HAEMORRHAGE INTRACRANIAL 28
679 INFUSION SITE REACTION 28
680 KIDNEY INFECTION 28
681 NEUTROPHIL COUNT INCREASED 28
682 PRODUCT COMMUNICATION ISSUE 28
683 RASH MACULAR 28
684 REFUSAL OF TREATMENT BY PATIENT 28
685 RHEUMATOID ARTHRITIS 28
686 ROTATOR CUFF SYNDROME 28
687 SALIVA ALTERED 28
688 SKIN ABRASION 28
689 SUSPICIOUSNESS 28
690 ULCER 28
691 VENTRICULAR TACHYCARDIA 28
692 VISUAL ACUITY REDUCED 28
693 AFFECTIVE DISORDER 27
694 DEFAECATION URGENCY 27
695 DRY THROAT 27
696 EAR INFECTION 27
697 EYE MOVEMENT DISORDER 27
698 FORMICATION 27
699 GENERALISED TONIC-CLONIC SEIZURE 27
700 HAEMOPTYSIS 27
701 INFUSION SITE INFECTION 27
702 INJECTION SITE REACTION 27
703 LIVER DISORDER 27
704 METABOLIC ENCEPHALOPATHY 27
705 MULTIPLE SCLEROSIS RELAPSE 27
706 NODULE 27
707 OROPHARYNGEAL DISCOMFORT 27
708 PANCYTOPENIA 27
709 PERICARDIAL EFFUSION 27
710 PULMONARY MASS 27
711 PYELONEPHRITIS 27
712 SLOW SPEECH 27
713 SMALL INTESTINAL OBSTRUCTION 27
714 STOMA COMPLICATION 27
715 TASTE DISORDER 27
716 TOOTH EXTRACTION 27
717 UPPER GASTROINTESTINAL HAEMORRHAGE 27
718 VITAMIN B12 DECREASED 27
719 WEIGHT FLUCTUATION 27
720 ADVERSE REACTION 26
721 APPETITE DISORDER 26
722 BIPOLAR DISORDER 26
723 CATHETER SITE NODULE 26
724 CHOLESTASIS 26
725 COAGULOPATHY 26
726 COMPULSIONS 26
727 DEMENTIA ALZHEIMER^S TYPE 26
728 DEVICE RELATED INFECTION 26
729 GENERAL PHYSICAL CONDITION ABNORMAL 26
730 HYPOTHERMIA 26
731 JOINT DISLOCATION 26
732 LOWER GASTROINTESTINAL HAEMORRHAGE 26
733 MASTICATION DISORDER 26
734 METABOLIC ACIDOSIS 26
735 MULTIPLE SYSTEM ATROPHY 26
736 PRODUCT DISTRIBUTION ISSUE 26
737 PSYCHIATRIC SYMPTOM 26
738 PULMONARY THROMBOSIS 26
739 SINUS BRADYCARDIA 26
740 SKIN LESION 26
741 APHONIA 25
742 BLEPHAROSPASM 25
743 CHOKING SENSATION 25
744 DEPENDENCE 25
745 DRUG DISPENSING ERROR 25
746 HYPERTONIA 25
747 HYPOCALCAEMIA 25
748 LIVER FUNCTION TEST ABNORMAL 25
749 MUSCLE DISORDER 25
750 PANIC DISORDER 25
751 SKIN CANCER 25
752 TOOTH DISORDER 25
753 TOOTH LOSS 25
754 TORTICOLLIS 25
755 VASCULAR ENCEPHALOPATHY 25
756 BLOOD SODIUM INCREASED 24
757 CARDIAC VALVE DISEASE 24
758 DEVICE DEFECTIVE 24
759 DIFFICULTY IN WALKING 24
760 DISEASE RECURRENCE 24
761 ENTERAL NUTRITION 24
762 EUTHANASIA 24
763 MAJOR DEPRESSION 24
764 MEDICAL DEVICE CHANGE 24
765 NEUTROPHIL COUNT DECREASED 24
766 PEMPHIGOID 24
767 RESPIRATORY RATE INCREASED 24
768 SECRETION DISCHARGE 24
769 SPINAL STENOSIS 24
770 TOOTHACHE 24
771 VENTRICULAR EXTRASYSTOLES 24
772 BONE DISORDER 23
773 CLOSTRIDIUM DIFFICILE COLITIS 23
774 CONCUSSION 23
775 DEVICE EXPULSION 23
776 GASTROINTESTINAL TUBE INSERTION 23
777 GASTROSTOMY 23
778 HAEMORRHAGIC ANAEMIA 23
779 HYPERNATRAEMIA 23
780 HYPOTONIA 23
781 HYPOVOLAEMIA 23
782 INCORRECT DRUG ADMINISTRATION DURATION 23
783 INFUSION SITE BRUISING 23
784 INFUSION SITE INDURATION 23
785 INJECTION SITE NODULE 23
786 ISCHAEMIC STROKE 23
787 LOGORRHOEA 23
788 LUNG NEOPLASM MALIGNANT 23
789 LYMPHADENOPATHY 23
790 PANCREATITIS ACUTE 23
791 PATIENT ELOPEMENT 23
792 PLATELET COUNT INCREASED 23
793 PRODUCT CLEANING INADEQUATE 23
794 PRODUCT COLOUR ISSUE 23
795 RESPIRATORY TRACT CONGESTION 23
796 SALIVA DISCOLOURATION 23
797 SCOLIOSIS 23
798 SCRATCH 23
799 THIRST 23
800 VITAMIN B6 DEFICIENCY 23
801 ACCIDENT 22
802 ANXIETY DISORDER 22
803 BACTERIAL INFECTION 22
804 BLOOD LACTATE DEHYDROGENASE INCREASED 22
805 BLOOD TRIGLYCERIDES INCREASED 22
806 BRAIN INJURY 22
807 CARDIOMYOPATHY 22
808 CATHETER SITE RELATED REACTION 22
809 CERVICAL VERTEBRAL FRACTURE 22
810 COVID-19 PNEUMONIA 22
811 DEVICE COLOUR ISSUE 22
812 DEVICE PLACEMENT ISSUE 22
813 DRUG TOXICITY 22
814 FEAR OF FALLING 22
815 GOUT 22
816 GRANULOCYTOPENIA 22
817 INCORRECT PRODUCT ADMINISTRATION DURATION 22
818 INFREQUENT BOWEL MOVEMENTS 22
819 INFUSION SITE NODULE 22
820 INFUSION SITE SWELLING 22
821 INTERNAL HAEMORRHAGE 22
822 MUSCULOSKELETAL DISCOMFORT 22
823 MYDRIASIS 22
824 OSTEOPENIA 22
825 PROSTATOMEGALY 22
826 RASH GENERALISED 22
827 RENAL FAILURE CHRONIC 22
828 SENSORY LOSS 22
829 SQUAMOUS CELL CARCINOMA 22
830 STOMA SITE DISCOMFORT 22
831 TEARFULNESS 22
832 ABSCESS 21
833 ANAPHYLACTIC REACTION 21
834 ANHEDONIA 21
835 BASAL CELL CARCINOMA 21
836 CANDIDA INFECTION 21
837 CATHETER SITE INDURATION 21
838 CORONAVIRUS INFECTION 21
839 DISABILITY 21
840 EYE SWELLING 21
841 FUNGAL INFECTION 21
842 HEPATIC STEATOSIS 21
843 INGUINAL HERNIA 21
844 INTENTIONAL SELF-INJURY 21
845 INTERSTITIAL LUNG DISEASE 21
846 INTESTINAL PERFORATION 21
847 IRON DEFICIENCY ANAEMIA 21
848 NEGATIVE THOUGHTS 21
849 PHOTOPHOBIA 21
850 PLASMA CELL MYELOMA 21
851 PULMONARY FIBROSIS 21
852 SARS-COV-2 TEST POSITIVE 21
853 SEASONAL ALLERGY 21
854 SNEEZING 21
855 SPINAL DISORDER 21
856 TERMINAL INSOMNIA 21
857 UTERINE PROLAPSE 21
858 WOUND INFECTION 21
859 WRONG DRUG ADMINISTERED 21
860 BENIGN NEOPLASM OF ADRENAL GLAND 20
861 BLADDER CATHETERISATION 20
862 BLOOD BILIRUBIN INCREASED 20
863 CEREBRAL ISCHAEMIA 20
864 COLITIS ISCHAEMIC 20
865 COLON CANCER 20
866 DRUG PRESCRIBING ERROR 20
867 ELECTROCARDIOGRAM ABNORMAL 20
868 GLOSSODYNIA 20
869 HALLUCINATION, TACTILE 20
870 HEPATIC FUNCTION ABNORMAL 20
871 HYPERTONIC BLADDER 20
872 INTERVERTEBRAL DISC DEGENERATION 20
873 LYMPHOCYTE COUNT DECREASED 20
874 MALABSORPTION 20
875 MULTIPLE ORGAN DYSFUNCTION SYNDROME 20
876 MULTIPLE SCLEROSIS 20
877 NASAL DISCOMFORT 20
878 PNEUMONITIS 20
879 PNEUMOTHORAX 20
880 PRODUCT PACKAGING DIFFICULT TO OPEN 20
881 RENAL INJURY 20
882 SLEEP ATTACKS 20
883 SOCIAL AVOIDANT BEHAVIOUR 20
884 SPINAL COLUMN STENOSIS 20
885 VOLVULUS 20
886 ARTERIOSCLEROSIS 19
887 ATRIAL FLUTTER 19
888 BLOOD CALCIUM DECREASED 19
889 BLOOD CHLORIDE DECREASED 19
890 BURSITIS 19
891 CARDIAC MURMUR 19
892 CARDIAC PACEMAKER INSERTION 19
893 CIRCULATORY COLLAPSE 19
894 DEVICE POWER SOURCE ISSUE 19
895 DIVERTICULUM 19
896 DRUG LEVEL INCREASED 19
897 DUODENAL ULCER 19
898 EAR PAIN 19
899 ENERGY INCREASED 19
900 ERUCTATION 19
901 EXOSTOSIS 19
902 FEELING DRUNK 19
903 FLUID OVERLOAD 19
904 HIP SURGERY 19
905 HYPOAESTHESIA ORAL 19
906 INCORRECT ROUTE OF DRUG ADMINISTRATION 19
907 INFUSION SITE MASS 19
908 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 19
909 LABORATORY TEST ABNORMAL 19
910 OSTEONECROSIS OF JAW 19
911 PRE-EXISTING CONDITION IMPROVED 19
912 PRODUCT SUPPLY ISSUE 19
913 PRURITUS GENERALISED 19
914 PULMONARY CONGESTION 19
915 SKIN HAEMORRHAGE 19
916 SUPINE HYPERTENSION 19
917 THYROID DISORDER 19
918 TONGUE DISORDER 19
919 ADDISON^S DISEASE 18
920 APPLICATION SITE RASH 18
921 ARTERIOSCLEROSIS CORONARY ARTERY 18
922 BREAST CANCER 18
923 CATHETER SITE BRUISE 18
924 CATHETER SITE HAEMORRHAGE 18
925 COGWHEEL RIGIDITY 18
926 COLITIS ULCERATIVE 18
927 CORONARY ARTERY OCCLUSION 18
928 DELUSIONAL DISORDER, UNSPECIFIED TYPE 18
929 DYSPHEMIA 18
930 END STAGE RENAL DISEASE 18
931 FACE OEDEMA 18
932 FACIAL BONES FRACTURE 18
933 FACIAL PARALYSIS 18
934 FEELING GUILTY 18
935 GASTROENTERITIS 18
936 GASTROINTESTINAL PAIN 18
937 IMPAIRED SELF-CARE 18
938 LIBIDO DECREASED 18
939 LUMBAR SPINAL STENOSIS 18
940 MACULAR DEGENERATION 18
941 NASAL DISCHARGE DISCOLOURATION 18
942 NEUROTOXICITY 18
943 PHOTOPSIA 18
944 PROCEDURAL COMPLICATION 18
945 PRODUCT ADMINISTRATION INTERRUPTED 18
946 RADIOISOTOPE SCAN ABNORMAL 18
947 RESTING TREMOR 18
948 SENSATION OF FOREIGN BODY 18
949 SKIN BURNING SENSATION 18
950 SKIN INFECTION 18
951 SLEEP DEFICIT 18
952 STATUS EPILEPTICUS 18
953 TACHYPNOEA 18
954 TENDON RUPTURE 18
955 THERMAL BURN 18
956 TOOTH INFECTION 18
957 VITAMIN D DECREASED 18
958 ABNORMAL LOSS OF WEIGHT 17
959 APRAXIA 17
960 ATRIOVENTRICULAR BLOCK FIRST DEGREE 17
961 BEZOAR 17
962 CACHEXIA 17
963 CARDIOVASCULAR DISORDER 17
964 CATARACT OPERATION 17
965 CATHETER SITE DISCHARGE 17
966 CATHETER SITE INFECTION 17
967 CEREBRAL HAEMATOMA 17
968 CHOLECYSTITIS 17
969 DIABETES MELLITUS INADEQUATE CONTROL 17
970 EYE PRURITUS 17
971 GLYCOSYLATED HAEMOGLOBIN INCREASED 17
972 HEART VALVE REPLACEMENT 17
973 HEPATIC FAILURE 17
974 HYPOMANIA 17
975 LEFT VENTRICULAR HYPERTROPHY 17
976 LOCAL SWELLING 17
977 MEDICAL DEVICE SITE PAIN 17
978 MUSCLE SPASTICITY 17
979 NERVE INJURY 17
980 ORAL CANDIDIASIS 17
981 PARKINSONIAN CRISIS 17
982 PERITONITIS 17
983 RENAL CYST 17
984 SHOCK 17
985 TENDONITIS 17
986 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 17
987 THERAPY PARTIAL RESPONDER 17
988 TOOTH FRACTURE 17
989 WRONG PATIENT RECEIVED PRODUCT 17
990 ACCIDENTAL EXPOSURE TO PRODUCT 16
991 ACUTE PSYCHOSIS 16
992 ASCITES 16
993 BACK INJURY 16
994 CEREBRAL HYPOPERFUSION 16
995 CLUMSINESS 16
996 COLITIS MICROSCOPIC 16
997 CYTOLYTIC HEPATITIS 16
998 DISTRACTIBILITY 16
999 FIBROMYALGIA 16